Twitter LinkedIn
    Wednesday, October 4
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Deals»BC Weighs Sale of $1.8 Billion Drugmaker Pharmathen
    Deals

    BC Weighs Sale of $1.8 Billion Drugmaker Pharmathen

    March 2, 20211 Min Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    BC Partners is weighing a sale of European generic drugmaker Pharmathen, which could be valued at as much as 1.5 billion euros ($1.8 billion), according to people familiar with the matter.

    The private equity firm is speaking with potential advisers as it considers options for the business, the people said, asking not to be identified discussing confidential information.

    Founded in 1969, Pharmathen develops and manufactures generic drugs that can be administered via tablets, drops and injection. Last year, the company had more than 30 products being lined up for launch, with a focus on the lucrative U.S. market, according to a company video. BC Partners acquired Pharmathen from its founding family for 475 million euros in 2015.

    Read More

    Source: Bloomberg Quint

    By Dinesh Nair

     

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    Deal PE Insider Private Equity
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Brookfield buys KKR’s Spanish solar company stake

    March 23, 2023

    Ethical Capital Partners buys Pornhub for an undisclosed sum

    March 18, 2023

    EQT Infrastructure acquires Madison Energy Investments

    December 22, 2022

    Euroclear moves into $9.8 trillion private asset market with Goji buy

    December 21, 2022

    Comments are closed.

    Other Articles

    Unicorn Capital Partners closes oversubscribed Fund IV at $450m hard cap

    June 4, 2021

    Goldman Sachs Asset Management invests $125m in supply chain cybersecurity provider

    April 20, 2022

    Pemberton supports financing of Elatec by Summit Partners

    April 21, 2021

    EQT launches EQT Active Core Infrastructure

    March 2, 2022

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2023 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.


    Lost password?